As previously reported, Guggenheim downgraded Acadia Pharmaceuticals (ACAD) to Neutral from Buy with a price target of $20, down from $23. The ...
Guggenheim analyst Yatin Suneja downgraded Acadia Pharmaceuticals (ACAD) to Neutral from Buy with a $20 price target Published first on TheFly – ...
Investing.com -- Guggenheim named Madison Square Garden Sports Corp (NYSE:MSGS) its "best idea" for 2025 given strong secular ...
Guggenheim named MSG Entertainment (MSGE) as a best idea entering 2025. Shares have slid about 23% since fiscal Q1 earnings ...
Guggenheim Active Allocation Fund (NYSE:GUG – Get Free Report) shares fell 0.5% during trading on Wednesday . The company traded as low as $14.78 and last traded at $14.87. 191,595 shares changed ...
With its stunning Frank Lloyd Wright design, the Guggenheim Museum is a piece of art in itself. Inside these rounded walls, ...
(128.9 × 194.9 cm). Solomon R. Guggenheim Museum, New York, Solomon R. Guggenheim Founding Collection 49.1184. Photo: Kristopher McKay, Solomon R. Guggenheim Museum, New York The ambitious ...
The Guggenheim's Orphism exhibition includes more than 90 artworks on display in its iconic rotunda, celebrating the 1910s ...
Naomi Beckwith, who holds a leadership role at the Guggenheim Museum in New York, said she would make navigating crises a ...
Guggenheim lowered the firm’s price target on AnaptysBio (ANAB) to $36 from $90 and keeps a Buy rating on the shares following the announcement ...
As the New Year unfolds, dance enthusiasts and art lovers can kick off 2025 with a dynamic showcase of new performances in the heart of the Hamptons. The inaugural Dance Out East, presented in ...